Effect of ticagrelor versus clopidogrel in reduction of ischaemic events and mortality in patients with acute coronary syndrome: A SWEDEHEART registry cohort study

Trial Profile

Effect of ticagrelor versus clopidogrel in reduction of ischaemic events and mortality in patients with acute coronary syndrome: A SWEDEHEART registry cohort study

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 Sep 2016

At a glance

  • Drugs Ticagrelor (Primary) ; Clopidogrel
  • Indications Acute coronary syndromes
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Sep 2016 New trial record
    • 19 Jul 2016 Results published in the European Heart Journal
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top